Princeton to offer meningitis B vaccine to 6,000

Princeton University says a meningitis vaccine not yet licensed for use in the U.S. will be made available on campus starting Dec. 9 to nearly 6,000 students.

The Ivy League school has experienced an outbreak of type B meningococcal disease, which is sometimes life-threatening.

Seven Princeton students and one student visitor have been stricken by the bacterial illness since March.

Princeton said Tuesday that the U.S. Centers for Disease Control and Prevention has officially recommended all as well as graduate students living in dorms and the Graduate College and annexes receive the new vaccine. Vaccination is also recommended for employees with certain medical conditions.

The vaccine is licensed for use in Europe and Australia but not in the U.S. The Food and Drug Administration is allowing its use at Princeton.

1 /5 (1 vote)
add to favorites email to friend print save as pdf

Related Stories

Booster dose of new meningitis vaccine may be beneficial

Sep 23, 2013

A study of 4CMenB, a new vaccine to protect against meningitis B bacteria (which can cause potentially fatal bacterial meningitis in children), shows that waning immunity induced by infant vaccination can be overcome by a ...

Recommended for you

Ebola isolation at US base 'pretty much vacation'

17 hours ago

With plenty of flat screen TVs, game nights and even an outdoor fire pit, life in isolation for members of the U.S. military who have returned from the Ebola mission in West Africa can look a lot like summer ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.